力大圖書
力 大 醫 學 圖 書 網          www.leaderbook.com.tw          歡迎使用  國民旅遊卡!!
帳號 密碼
加入會員 | 首頁 | 服務 | 討論 | 留言 | 行銷回應 | 代訂 | 購物車 | 預訂清單
  
Search
      圖書搜尋

 - 進階搜尋
  代訂書籍
  加購書籍專區
Classes
      圖書類別
國民旅遊卡使用須知
購買注意事項
力大中文圖書
橘井文化系列叢書
免疫風濕科
內分泌科
內科(家醫科及實証醫學)
婦產科
眼科
病理科(檢驗科)
外科
耳鼻喉科(聽力和語言治療)
泌尿科
胸腔內科(重症醫學)
胸腔外科
腫瘤科(血液科)
放射腫瘤科
麻醉科(疼痛科)
獸醫科
神經外科
神經內科
小兒科
心臟內科
心臟外科
急診科
感染科
放射線科
核醫科
牙科(口腔外科)
皮膚科(醫學美容)
精神科
胃腸科
骨科
腎臟科
整形外科
藥劑科
復健科(運動醫學)
護理科
限量特價專區
SPRINGER庫存出清專區
解剖學(組織學)
基礎醫學科
醫學系列書籍
醫學模型
醫學掛圖
inkling
 
 
 
-■ ■ ■ ■ ■ ■ 圖 書 介 紹
Comprehensive Dermatologic Drug Therapy, 2nd Edition
-皮膚科(醫學美容)
- 編號: 0-000000000014160247199
- 作者:Stephen E. Wolverton, MD
- 原價-3900    - (熱賣價)2800     - 節省 ↓28%
- 加入購物車
推薦指數:
- 內容介紹
Comprehensive Dermatologic Drug Therapy, 2nd Edition
By Stephen E. Wolverton, MD

1104 pages 80 ills
Trim size 10 1/16 X 7 1/16 in
Copyright 2007
Description
Safely and effectively prescribe today’s full spectrum of topical, intralesional, and systemic drugs for dermatologic disorders! Dr. Steven E. Wolverton and a team of leading international experts explain what drugs to use, when to use them...and what to watch out for. This invaluable quick reference tool provides full-text explanations as well as at-a-glance summaries of key pharmacologic information, as well as treatment protocols and associated costs.



Key Features

Provides at-a-glance access to key information including summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols.
Features a consistent organization throughout to expedite fast reference.
Provides purchase information for major drugs, to help you and your patients.
Includes a highly detailed, disease-specific index, helping you to evaluate drug options for each disease discussed.



New to this Edition

Includes handheld software for on-the-go reference.
Highlights key controversies and provides expert guidance in a Question and Answer feature.
Presents new chapters on TNF Inhibitors, Signal II Cytokine Inhibitors, Pimicrolimus, IV Immunoglobulin, Drug-Induced Malignancies, Polymorphisms, and non-dermatologic drugs related to dermatologic problems.
Features updates on new drug findings and new research, especially findings on predicting an individual response to drugs on the basis of ethnicity and gender.

Table of Contents
I. Introduction
1. Basic Principles of Pharmacology (Stephen E. Wolverton) 2. Principles for Maximizing the Safety of Dermatologic Drug Therapy (Stephen E. Wolverton) 3. Polymorphisms: Why Individual Drug Responses Vary (Benjamin N. Lockshin, Stephen E. Wolverton)
II. Systemic Drugs for Infectious Diseases
4. Systemic Antibacterial Agents (Neda Ashourian, Philip R. Cohen) 5. Systemic Antifungal Agents (Aditya K. Gupta ) 6. Systemic Antiviral Agents (Y. Connie Chang, Vandana K. Madkan, Karan Sra, Daniel A. Carrasco, Patricia C. Lee, Stephen K. Tyring)
III. Systemic Immunomodulatory and Antiproliferative Drugs
7. Systemic Corticosteriods (Stephen E. Wolverton) 8. Methotrexate (Jeffrey P. Callen, Carol L. Kulp-Shorten, Stephen E. Wolverton) 9. Azathioprine (Stephanie Silos Badalamenti, Francisco A. Kerdel) 10. Cytotoxic Agents (Clifford Perlis, Teddy D. Pan, Charles J. McDonald) 11. Cyclosporine (Chai Sue Lee, John Y.M. Koo) 12.Dapsone (Russell P. Hall III, Clinzo P. Mickle) 13. Antimalarial Agents (Jeffrey P. Callen, Charles Camisa) 14. Systemic Retinoids (Timothy J. Patton, Matthew J. Zirwas, Stephen E. Wolverton) 15. Interferons (Brian Berman, Francisco Flores, Deborah Zel)l
IV. Drugs Used in Conjunction with Ultraviolet or Visible Light
16. PUVA Photochemotherapy (Warwick L. Morison) 17. Extracorporeal Photochemotheraphy (Photopheresis) (Michael Girardi, Peter W. Heald) 18. Photodynamic Therapy (Robert Bissonnette, Jaggi Rao)
V. Biological Therapeutics
19. Tumor Necrosis Factor (TNF) Inhibitors (Stephanie Mehlis, Kenneth B. Gordon) 20. T-Cell Activation Inhibitors (Mark G. Lebwohl, Sapna Rao Palep)
VI. Miscellaneous Systemic Drugs
21. Antihistamines (Malcolm W. Greaves) 22. Vasoactive and Antiplatelet Agents (Seth B. Forman, Algin B. Garrett) 23. Antiandrogens and Androgen Inhibitors (Marty E. Sawaya) 24. Psychotropic Agents (Chai Sue Lee, John Y.M. Koo) 25. Intravenous Immunoglobulin Therapy (Kai Thomas, Anita Ruetter, Thomas A. Luger) 26. Miscellaneous Systemic Drugs (Alfred L. Knable Jr., Loretta S. Davis) 27. Drugs for the Skinternist (Michelle Pelle)
VII. Topical Drugs for Infectious Diseases
28. Topical Antibaterial Agents (Deborah J. Yang, Long T. Quan, Sylvia Hsu) 29. Topical Antifungal Agents (Rhea M. Phillips, Theodore Rosen) 30. Topical and Intralesional Antiviral Agents (Pranav B. Sheth) 31. Antiparasitic Agents (Benjamin N. Lockshin)
VIII. Topical Immunomodulatory and Antiproliferative Drugs
32. Topical Corticosteroids (Michael R. Warner, Charles Camisa) 33. Topical Retinoids (Naveed Sami, Julie C. Harper) 34. Topical and Intralesional Chemotherapeutic Agents (Eunice Y. Tsai, Herschel S. Zackheim, Youn H. Kim) 35. Topical Contact Allergens (Andrew N. Lin) 36. Topical Calcineurin Inhibitors (Andrew N. Lin) 37. Topical Vitamin D3 (Yolanda Rosi Helfrich, Dana L. Sachs, Sewon Kang)
IX. Miscellaneous Topical Drugs
38. Sunscreens (Stanley B. Levy) 39. Therapeutic Shampoos (Robert T. Brodell, Kevin D. Cooper) 40. Alpha-Hydroxy Acids (Amy B. Lewis, Helen Radoszycki) 41. Agents Used for Treatment of Hyperkeratosis (Adam B. Hessel, Julio C. Cruz-Ramon, Dana Marshall Klinger, Andrew N. Lin) 42. Cosmetic Therapy (Zoe Diana Draelos) 43. Miscellaneous Topical Agents (Seth B. Forman) 44. Insect Repellents (Mark S. Fradin) 45. Systemic Adverse Effects Due To Topical Medications (Peter J. Aronson) 46. Compounding in Dermatology (Linda F. McElhiney, Scott M. Ravis)
X. Injectable and Mucosal Routes of Drug Administration
47. Local Anesthetics (Michael J. Huether, David G. Brodland) 48. Botulinum Toxin Injections (Christian Murray, Nowell Solish) 49. Oral Mucosal Therapeutics (Ginat Wintermeyer Mirowski, Ernest Lee)
XI. Major Adverse Effects from Systemic Drugs
50. Hepatotoxicity of Dermatologic Drug Therapy (Stephen E. Wolverton) 51. Hematologic Toxicity of Dermatologic Drug Therapy (Kathleen A. Remlinger) 52. Drug Induced Malignancies (Stephen E. Wolverton) 53. Dermatologic Drugs During Pregnancy and Lactation (Barbara R. Reed) 54. Drug Interactions (Lori E. Shapiro, Neil H. Shear) 55. Cutaneous Drug Reactions with Systemic Features (Sandra R. Knowles, Neil H. Shear)
XII. Special Pharmacology and Therapeutic Topics
56. Pharmacoeconomics (Marc Alan Darst, Jennifer Reddan) 57. Informed Consent and Risk Management (Stephen E. Wolverton, Marshall B. Kapp ) 58. FDA Drug Approval Process (William H. Eaglstein) 59. Pharmacovigilance: Verifying that Drugs Remain Safe (Joel M. Gelfand) 60. Dermatologic Drug Therapy in Children (Christopher M. Bohyer)
Index
Appendices





歡迎使用國民旅遊卡
歡迎使用國民旅遊卡
其他相關書藉
  請輸入關鍵字
相 關 書 藉
Essential Clinical Immunology
- 皮膚科(醫學美容)
- 作者:Helen Chapel
Comprehensive Dermatologic Drug Therapy, 2nd Edition
- 皮膚科(醫學美容)
- 作者:Stephen E. Wolverton, MD
Dermatopathology: Expert Consult - Online and Print, 2/E 2014
- 皮膚科(醫學美容)
- 作者:Dirk Elston MD
Historical Atlas of Dermatology and Dermatologists
- 皮膚科(醫學美容)
- 作者:John Thorne Crissey
50 Cases in Dermatological Medicine
- 皮膚科(醫學美容)
- 作者:Daniel Creamer
--- more
[ 積點系統 ]
您已經累積多少點數您知道嗎?別忘了登錄會員,察看您的點數,獎品就等您來拿喲!
[ 訂購辦法 ]
您還不知道要在本網站如何購物嗎?我們將會提供給您訂購的方法及購物相關資訊喲!讓您彈指間取得想要的書藉。
 
      圖書搜尋         本網站購物機制使用 SSL+ 加密技術,請放心購物 Safe100%

| 加入會員 | 回首頁 | 服務中心 | 行銷回應 | 購物須知 | 會員條款 | 關於力大 | 權益申明 | 合作對象 |

本站內容為 力大圖書有限公司 所有,未經同意,請勿任意引用轉載
電話:(02)2733-2592 傳真:(02)2732-5743 E-mail:service@leaderbook.com.tw
力大圖書:台北市和平東路二段90巷2號4樓之2  台中分店:臺中榮總婦幼大樓1F
Copyright 2002-2010 LeaderBook CO.,LTD All rights reserved.